| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1992PNAS...8910633B |
| P356 | DOI | 10.1073/PNAS.89.22.10633 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC50395 |
| https://europepmc.org/articles/PMC50395?pdf=render | ||
| P932 | PMC publication ID | 50395 |
| P698 | PubMed publication ID | 1359543 |
| P5875 | ResearchGate publication ID | 21795253 |
| P50 | author | Bert W. O'Malley | Q827492 |
| Ming-Jer Tsai | Q90840739 | ||
| Sophia Y Tsai | Q90840742 | ||
| P2093 | author name string | M. J. Tsai | |
| A. Baniahmad | |||
| P2860 | cites work | Regulation of two c-erbA messenger ribonucleic acids in rat GH3 cells by thyroid hormone | Q69924070 |
| Syndromes of thyroid hormone resistance | Q72948360 | ||
| A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor | Q24555696 | ||
| A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds | Q24624938 | ||
| The protein Id: a negative regulator of helix-loop-helix DNA binding proteins | Q28237471 | ||
| A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor | Q28302131 | ||
| Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors | Q29615768 | ||
| Trans-activation by thyroid hormone receptors: functional parallels with steroid hormone receptors. | Q33855825 | ||
| Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone | Q34203456 | ||
| v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. | Q35000459 | ||
| Molecular diagnosis and characterization of thyroid hormone resistance syndromes | Q36474441 | ||
| Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function | Q36684411 | ||
| Transcriptional repression in eukaryotes | Q37941786 | ||
| Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site | Q38340913 | ||
| Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression | Q38341818 | ||
| Transcriptional repression of eukaryotic promoters | Q38365817 | ||
| Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors | Q40348625 | ||
| Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements | Q41347641 | ||
| Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene | Q41348118 | ||
| Regulation of progesterone receptor-mediated transcription by phosphorylation | Q41710148 | ||
| The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements | Q43679715 | ||
| Functional domains of the human glucocorticoid receptor | Q43734761 | ||
| Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist | Q44537287 | ||
| Identification of a thyroid hormone receptor that is pituitary-specific | Q44748833 | ||
| Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei | Q45046838 | ||
| Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity | Q45217737 | ||
| Homozygosity for a Dominant Negative Thyroid Hormone Receptor Gene Responsible for Generalized Resistance to Thyroid Hormone* | Q45760645 | ||
| v-erbA Oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action | Q46122290 | ||
| The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors. | Q53505031 | ||
| Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. | Q54276254 | ||
| Expression of the v-erbA product, an altered nuclear hormone receptor, is sufficient to transform erythrocytic cells in vitro. | Q54348884 | ||
| A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. | Q54713263 | ||
| Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product | Q59098062 | ||
| Mutations that alter both localization and production of a yeast nuclear protein | Q61631665 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tretinoin | Q29417 |
| transcription | Q177900 | ||
| P304 | page(s) | 10633-10637 | |
| P577 | publication date | 1992-11-01 | |
| 1992-11-15 | |||
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses | |
| P478 | volume | 89 |
| Q36553911 | A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. |
| Q71902705 | A Purkinje cell protein-2 intronic thyroid hormone response element binds developmentally regulated thyroid hormone receptor-nuclear protein complexes |
| Q35885778 | A composite intragenic silencer domain exhibits negative and positive transcriptional control of the bone-specific osteocalcin gene: promoter and cell type requirements |
| Q33844628 | A highly selective, label-free, homogenous luminescent switch-on probe for the detection of nanomolar transcription factor NF-kappaB. |
| Q24563282 | A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors |
| Q28289864 | A transcriptional co-repressor that interacts with nuclear hormone receptors |
| Q77957413 | Amphibian metamorphosis as a model for studying the developmental actions of thyroid hormone |
| Q77988411 | Amphibian metamorphosis as a model for studying the developmental actions of thyroid hormone |
| Q35050227 | An unliganded thyroid hormone receptor causes severe neurological dysfunction |
| Q37549897 | CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma |
| Q42222828 | DNA-induced unfolding of the thyroid hormone receptor α A/B domain through allostery. |
| Q54118071 | Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. |
| Q36664756 | Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor |
| Q36549937 | Genetic dissection of thyroid hormone receptor beta: identification of mutations that separate hormone binding and transcriptional activation |
| Q73692255 | Identification and characterization of the AF-1 transactivation domain of thyroid hormone receptor beta1 |
| Q35615116 | In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation |
| Q39812323 | Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein |
| Q36556508 | Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone |
| Q28138285 | Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita |
| Q24671522 | Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator |
| Q38295595 | Ligand modulates the interaction of thyroid hormone receptor beta with the basal transcription machinery |
| Q24311650 | Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor |
| Q39457575 | Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and a novel posterior truncation. |
| Q36566667 | Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region |
| Q36655870 | Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor |
| Q35004452 | NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth. |
| Q40634903 | Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K. |
| Q48796600 | Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11 July 1993, Cambridge, UK. |
| Q33835161 | Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin |
| Q28217579 | RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding |
| Q30499918 | Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function |
| Q40898485 | Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor |
| Q47762482 | Role of the conserved C-terminal region of thyroid hormone receptor-alpha in ligand-dependent transcriptional activation |
| Q33716064 | Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor beta |
| Q64092855 | Tail Resorption During Metamorphosis in Tadpoles |
| Q37229683 | The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor |
| Q40015924 | The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation |
| Q28144226 | The minimal repression domain of MBD2b overlaps with the methyl-CpG-binding domain and binds directly to Sin3A |
| Q39961304 | The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth |
| Q24646988 | The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing |
| Q41119685 | Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors |
| Q40906060 | Thyroid hormone-independent interaction between the thyroid hormone receptor beta2 amino terminus and coactivators |
| Q24515375 | Transcriptional repression by the insulator protein CTCF involves histone deacetylases |
| Q39465831 | Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor |
| Q40231308 | Two silencing sub-domains of v-erbA synergize with each other, but not with RXR. |
Search more.